Safety of oral chronic administration of ivabradine modified release formulation compared to ivabradine immediate release formulation, in patients with stable coronary artery disease

Registry ID

EUCTR2012-001668-31

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Institut de Recherches Internationales Servier

Start date

2012-10-05

Completion date

2014-04-14

Last update

2026-08-16

Conditions

• Stable coronary artery disease

Summary

To compare the safety profiles of the ivabradine modified release (MR) formulation and ivabradine immediate release (IR) formulation over a 6-month period

Locations

• , , Germany
• , , UK
• , , Bulgarian Drug Agency
• , , Spain
• , , Netherlands
• , , Italy
• , , Slovakia
• , , Hungary

View on source registry